Drug recall · February 5, 2014
Soliris recall
Why: Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.
- Lots / codes
Lot #: 10001-1, Exp 07/14; 10010A, Exp 10/15
- Quantity
- 21,661 vials
- Company
- Alexion Pharmaceuticals, Inc., Cheshire, CT
- Distribution
- Nationwide, Puerto Rico, Jamaica, and Grenada.
- Initiated
- November 4, 2013 · Voluntary: Firm initiated
- Classified
- January 30, 2014
- Reported
- February 5, 2014
- Ended
- March 2, 2015
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.